menu
    • menu
    [{"orgOrder":0,"company":"Immunorizon","sponsor":"Purple Biotech","pharmaFlowCategory":"D","therapeuticArea":"Oncology","country":"","productType":"Large molecule","year":"2023","type":"Acquisition","leadProduct":"Tri-specific Antibody","moa":"","graph1":"Oncology","graph2":"Preclinical","graph3":"Immunorizon","amount2":0.10000000000000001,"highestDevelopmentShortName":"Preclinical","therapeuticAreaShortName":"Oncology","amount2New":0.10000000000000001,"dosageForm":"","sponsorNew":"Immunorizon \/ Purple Biotech","highestDevelopmentStatusID":"4","companyTruncated":"Immunorizon \/ Purple Biotech"}]

    Find Clinical Drug Pipeline Developments & Deals by Immunorizon

    Menu

    Immunorizon

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            Immunorizon

                            Netherlands arrow
                            Pharmtech & Ingredients
                            Not Confirmed

                            Immunorizon

                            Netherlands arrow
                            Pharmtech & Ingredients
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Tri-specific Antibody

                            Therapeutic Area : Oncology

                            Study Phase : Preclinical

                            Sponsor : Purple Biotech

                            Deal Size : $101.0 million

                            Deal Type : Acquisition

                            DEALS_DEV arrow-down

                            Purple Biotech Expands Pipeline of First-in-Class Therapeutics with Acquisition of Immunorizon and its Portfol...

                            Details : The acquisition will provide Purple Biotech with an expanded portfolio of investigational tri-specific antibody compounds that target multiple antigens and offer the potential to further expand to additional targets.

                            Brand Name : Undisclosed

                            Molecule Type : Large molecule

                            Upfront Cash : $3.5 million

                            February 02, 2023

                            Lead Product(s) : Tri-specific Antibody

                            Therapeutic Area : Oncology

                            Highest Development Status : Preclinical

                            Sponsor : Purple Biotech

                            Deal Size : $101.0 million

                            Deal Type : Acquisition

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth